GeneDx Holdings Corp. (WGS) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$13.08M | +43.7% |
| 2024 | -$23.21M | +87.1% |
| 2023 | -$180.60M | +73.0% |
| 2022 | -$667.65M | -49.6% |
| 2021 | -$446.15M | -84.4% |
| 2020 | -$241.99M | -695.7% |
| 2019 | -$30.41M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$13.08M | +43.7% |
| 2024 | -$23.21M | +87.1% |
| 2023 | -$180.60M | +73.0% |
| 2022 | -$667.65M | -49.6% |
| 2021 | -$446.15M | -84.4% |
| 2020 | -$241.99M | -695.7% |
| 2019 | -$30.41M | — |